AI startup Nucleai has immuno-oncology treatment failures in its sightsIsraeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond Share XAI startup Nucleai has immuno-oncology treatment failures in its sightshttps://pharmaphorum.com/news/ai-startup-nucleai-has-immuno-oncology-treatment-failures-in-its-sights/
AI chatbots step up to help fight COVID-19The COVID-19 pandemic has placed enormous stress on both healthcare systems and researchers, and people all across the Share XAI chatbots step up to help fight COVID-19https://pharmaphorum.com/views-analysis-digital/ai-chatbots-step-up-to-help-fight-covid-19/
AI health record scanning could identify pancreatic cancer earlyArtificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them Share XAI health record scanning could identify pancreatic cancer earlyhttps://pharmaphorum.com/news/ai-health-record-scanning-could-identify-pancreatic-cancer-early/
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19AI and machine learning drug development firm BenevolentAI has highlighted further data supporting its hypothesis that Eli Lilly’s Olumiant (baricitinib) could be Share XNew research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19https://pharmaphorum.com/news/new-research-from-benovelentai-supports-use-of-lillys-olumiant-in-covid-19/
BERG taps supercomputer to speed AI discovery of COVID-19 drugsUS artificial intelligence company BERG has agreed a deal to access a federal supercomputer to help it hunt Share XBERG taps supercomputer to speed AI discovery of COVID-19 drugshttps://pharmaphorum.com/news/berg-taps-supercomputer-to-speed-ai-discovery-of-covid-19-drugs/
Lilly takes AI-selected Olumiant into phase 3 for COVID-19Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis Share XLilly takes AI-selected Olumiant into phase 3 for COVID-19https://pharmaphorum.com/news/lilly-takes-ai-selected-olumiant-into-phase-3-for-covid-19/
AI chatbot aims to fight social isolation in older peopleSpecialist investor Startup Health has backed an artificial intelligence (AI) chatbot that aims to fight social isolation in Share XAI chatbot aims to fight social isolation in older peoplehttps://pharmaphorum.com/news/ai-chatbot-aims-to-fight-social-isolation-in-older-people/
5 pitfalls AI healthcare start-ups need to avoidArtificial intelligence (AI) has now moved beyond its initial hype towards becoming a key part of the pharma Share X5 pitfalls AI healthcare start-ups need to avoidhttps://pharmaphorum.com/views-analysis-digital/5-pitfalls-ai-healthcare-start-ups-need-to-avoid-early-in-their-journey/
Coronavirus news roundup – 29/05/2020A series of vaccines and drugs are being fast-tracked through the big pharma pipeline as part of a Share XCoronavirus news roundup – 29/05/2020https://pharmaphorum.com/views-and-analysis/coronavirus-news-roundup-29-05-2020/
